| Literature DB >> 30273597 |
Munezumi Fujita1, Yuhei Yamamoto2, Jing-Jing Jiang3, Toru Atsumi3, Yuki Tanaka3, Takuto Ohki3, Naoki Murao2, Emi Funayama2, Toshihiko Hayashi2, Masayuki Osawa2, Taku Maeda2, Daisuke Kamimura4, Masaaki Murakami5.
Abstract
Keloids mark a chronic inflammatory disease characterized by a fibroproliferative disorder of the skin. A genome-wide association study showed that single-nucleotide polymorphism rs8032158 in the neural precursor cell-expressed NEDD4 gene, which has six protein-coding transcript variants (TVs), is genetically linked to keloids. Here, we show that the high frequency of risk allele C in rs8032158 in keloid patients is associated with a selectively higher expression of TV3 of NEDD4 to activate the NF-κB pathway. Comparisons of keloid scars with normal skin samples that do not have the single-nucleotide polymorphism allele and were derived from different anatomical sites showed stronger expressions of NEDD4 TV3 and activated forms of NF-κB and STAT3 in keloid scars. Forced expression or selective knockdown of NEDD4 TV3 increased or decreased NF-κB activation in vitro. Furthermore, NEDD4 knockdown suppressed NF-κB-dependent inflammation development in vivo. Mechanistic analysis showed that NEDD4 TV3 is involved in NF-κB activation through its association with the adaptor protein RIP. These results suggest that NEDD4 TV3 is a potential diagnostic marker and therapeutic target for chronic skin diseases, including keloid.Entities:
Year: 2018 PMID: 30273597 DOI: 10.1016/j.jid.2018.07.044
Source DB: PubMed Journal: J Invest Dermatol ISSN: 0022-202X Impact factor: 8.551